Dr. Reddy’s Laboratories launches DailyBloom IBS : India’s first integrated care plan for irritable bowel syndrome

By on    Healthcare Industry News  

Dr. Reddy’s Laboratories launches DailyBloom IBS : India’s first integrated care plan for irritable bowel syndrome

Dr. Reddy’s Laboratories Ltd., a globally recognized pharmaceutical company, has unveiled DailyBloom IBS, marking a significant advancement in the management of Irritable Bowel Syndrome (IBS) in India. Launched on World IBS Day, DailyBloom IBS is the first comprehensive care plan in India tailored specifically for IBS, incorporating a mobile application developed in-house for continuous care. […]

Alfasigma acquires IBS-C drug Zelnorm from Sloan Pharma

By on    Pharma Industry News  

Alfasigma acquires IBS-C drug Zelnorm from Sloan Pharma

Alfasigma acquisition of Zelnorm : Alfasigma USA, a subsidiary of Italian pharmaceutical company Alfasigma, has acquired IBS-C drug Zelnorm (tegaserod), a prescription treatment for irritable bowel syndrome with constipation (IBS-C), from Sloan Pharma, a subsidiary of US WorldMeds, for an undisclosed price. Alfasigma intends to relaunch Zelnorm in the US. The IBS-C drug, which was […]